Viewing Study NCT00954005


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2025-12-26 @ 1:55 AM
Study NCT ID: NCT00954005
Status: TERMINATED
Last Update Posted: 2015-08-19
First Post: 2009-08-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
Sponsor: German Low Grade Lymphoma Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module